Aclaris Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Aclaris Therapeutics Inc
TickerACRS
CIK #0001557746
CUSIP00461U105
SectorLife Sciences - Pharmaceutical Preparations
AddressSuite 400, 101 Lindenwood Drive, Malvern, PA 19355
Source [EDGAR]
CIK Filing 2011 - 2024
[0001557746] 10-K
[0001557746] 10-Q
[0001557746] 3
[0001557746] 4
[0001557746] 8-K
[0001557746] D
[0001557746] SC 13D
[0001557746] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Biotechnology Value Fund L P Aclaris Therapeutics Inc [2023-03-16] 2.7
RA Capital Management LP Aclaris Therapeutics Inc [2022-04-25] 7.1
Venrock Healthcare Capital Partners II LP Aclaris Therapeutics Inc [2022-02-14] 7.5
Wellington Management Group LLP Aclaris Therapeutics Inc [2022-02-04] 0.05
BlackRock Inc Aclaris Therapeutics Inc [2022-02-04] 6.7
Biotechnology Value Fund L P Aclaris Therapeutics Inc [2022-01-24] 3.4
Foresite Capital Fund III LP Aclaris Therapeutics Inc [2020-10-27] 3.8
Rock Springs Capital Management LP Aclaris Therapeutics Inc [2020-10-26] 5.18
Adage Capital Partners GP LLC Aclaris Therapeutics Inc [2020-06-26] 5.97
Samsara Biocapital LP Aclaris Therapeutics Inc [2020-03-06] 5.2
EcoR1 Capital LLC Aclaris Therapeutics Inc [2020-02-14] 5.0
Renaissance Technologies LLC Aclaris Therapeutics Inc [2020-02-12] 6.72
MFN Partners Management LP Aclaris Therapeutics Inc [2019-10-31] 9.7
Arkin Moshe Aclaris Therapeutics Inc [2019-10-15] 8.02
Morgan Stanley Aclaris Therapeutics Inc [2019-08-29] 5.0
Rock Springs Capital Management LP Aclaris Therapeutics Inc [2019-07-29] 5.09
Man Group PLC Aclaris Therapeutics Inc [2019-07-09] 5.87
Broadfin Capital LLC Aclaris Therapeutics Inc [2019-01-29] 5.57
D E Shaw & Co LP Aclaris Therapeutics Inc [2018-11-01] 5.0
BlackRock Inc Aclaris Therapeutics Inc [2018-02-01] 7.1
Flynn James E Aclaris Therapeutics Inc [2017-10-10] 5.9
Perceptive Advisors LLC Aclaris Therapeutics Inc [2017-02-14] 5.88
Franklin Resources Inc Aclaris Therapeutics Inc [2016-02-03] 8.2
Vivo Ventures Fund VII LP Aclaris Therapeutics Inc [2015-10-20] 11.0
Sofinnova Venture Partners VIII LP Aclaris Therapeutics Inc [2015-10-16] 11.0
FMR LLC Aclaris Therapeutics Inc [2015-10-14] 0.0
RA Capital Management LLC Aclaris Therapeutics Inc [2015-10-13] 11.5
Form 3/4/5 Filer 2011 - 2024
Reasons Bryan M.
Aclaris Therapeutics, Inc.
Powell Andrew Kenneth William
Mehra Anand
Molineaux Christopher P.
Gowen Maxine
Milano Vincent
Humphries William D.
Schiff Andrew N
Manion Douglas J.
Balthaser Kevin
Walker Neal
Monahan Joseph
Loerop James
Cawkwell Gail
Ruffo Frank
Ali-Jackson Kamil
Foresite Capital Fund V, L.P.
Tananbaum James B.
Foresite Capital Management V, LLC
Foresite Capital Fund IV, L.P.
Foresite Capital Management IV, LLC
Foresite Capital Management III, LLC
Foresite Capital Fund III, L.P.
Gordon David N.
Flynn James E
Deerfield Mgmt L.P.
Deerfield Management Company LP Series C
Deerfield Special Situations Fund, L.P.
Deerfield Partners LP
Shanler Stuart
Powala Christopher
Fair Brett
Tullman Stephen A.
FMR LLC
Bierly Rick
Vivo Ventures VII LLC
Vivo Ventures Fund VII, L.P.
Vivo Ventures VII Affiliates Fund, L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
RA Capital Management LP
Cha Albert
Akkaraju Srinivas
Powell Michael
Sofinnova Venture Partners VIII, L.P.
Healy James
Sofinnova Management VIII, L.L.C.
Form 13F Holdings
Firm Period DFND Voting Shares
Wellington Management Group LLP [2023-03-31] DFND 0.0 7,372,601.0
BlackRock Inc. [2023-03-31] SOLE 5,024,446.0 5,114,149.0
RA Capital Management LP [2023-03-31] SOLE 0.0 4,398,453.0
Rock Springs Capital Management LP [2023-03-31] SOLE 3,961,849.0 3,961,849.0
Bain Capital Life Sciences Investors, LLC [2023-03-31] SOLE 3,400,000.0 3,400,000.0
Citadel Advisors LLC [2023-03-31] DFND 3,361,064.0 3,361,064.0
BVF Inc/IL [2023-03-31] DFND 0.0 3,360,941.0
Braidwell LP [2023-03-31] SOLE 3,269,094.0 3,269,094.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 3,044,213.0
Foresite Capital Management IV, LLC [2023-03-31] SOLE 2,808,034.0 2,808,034.0
Deep Track Capital LP [2023-03-31] SOLE 1,708,971.0 1,708,971.0
Holocene Advisors LP [2023-03-31] SOLE 1,685,056.0 1,685,056.0
Ikarian Capital LLC [2023-03-31] SOLE 1,621,463.0 1,621,463.0
Great Point Partners LLC [2023-03-31] DFND 0.0 1,441,581.0
State Street Corp [2023-03-31] DFND 1,329,853.0 1,423,354.0
Point72 Asset Management LP [2023-03-31] DFND 0.0 1,344,600.0
Foresite Capital Management V, LLC [2023-03-31] SOLE 1,258,243.0 1,258,243.0
Renaissance Technologies LLC [2023-03-31] SOLE 1,104,372.0 1,252,152.0
Adage Capital Partners GP LLC [2023-03-31] SOLE 1,180,000.0 1,180,000.0
Geode Capital Management LLC [2023-03-31] DFND 1,114,572.0 1,114,572.0
Deutsche Bank AG [2023-03-31] DFND 140,762.0 1,102,197.0
Samlyn Capital LLC [2023-03-31] DFND 1,051,568.0 1,051,568.0
VR Adviser LLC [2023-03-31] SOLE 1,040,754.0 1,040,754.0
Vivo Capital LLC [2023-03-31] SOLE 898,631.0 898,631.0
Caption Management LLC [2023-03-31] SOLE 879,304.0 879,304.0
SilverArc Capital Management LLC [2023-03-31] SOLE 871,500.0 871,500.0
FMR LLC [2023-03-31] DFND 751,342.0 753,041.0
Samsara Biocapital LLC [2023-03-31] SOLE 696,171.0 696,171.0
Laurion Capital Management LP [2023-03-31] SOLE 686,533.0 686,533.0
Morgan Stanley [2023-03-31] DFND 667,041.0 676,618.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com